Jelmer Raaijmakers
6PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Nov 10, 2025
Enhanced antimycobacterial efficacy of simulated inhaled clofazimine versus oral clofazimine in combination with azithromycin and ethambutol in a hollow-fiber system.Jelmer Raaijmakers, Rob Aarnoutse, Lindsey Te Brake
|May 07, 2025
Bedaquiline does not enhance a clofazimine-azithromycin-ethambutol regimen against <i>Mycobacterium avium</i> in the hollow-fiber system.J Raaijmakers, S Salillas, R Aarnoutse
|Jan 23, 2024
Clofazimine as a substitute for rifampicin improves efficacy of <i>Mycobacterium avium</i> pulmonary disease treatment in the hollow-fiber model.Sandra Salillas, Jelmer Raaijmakers, Rob E Aarnoutse
|Oct 25, 2023
The role of rifampicin within the treatment of <i>Mycobacterium avium</i> pulmonary disease.Jodie A Schildkraut, Jelmer Raaijmakers, Rob Aarnoutse
|Sep 27, 2023
Development and validation of a bioanalytical assay for the measurement of total and unbound teicoplanin in human serum.J W A Mouton, J Raaijmakers, M Botterblom
|Jul 22, 2021
The role of amikacin in the treatment of nontuberculous mycobacterial disease.Jelmer Raaijmakers, Jodie Anne Schildkraut, Wouter Hoefsloot
Pageof 1
